01.01.70
(AP) CHELMSFORD, Roe. — Zoll Medical Corp.'s fiscal first-quarter profit grew 70 percent on greater
sales of its LifeVest wearable defibrillator and other devices.
The gathering said Thursday that its net income rose to $6.6 million, or 29 cents per serving, from $3.9 million, or 18 cents per share. Its revenue increased 18 percent to $133.7 million.
The results
topped Go broke Street expectations for earnings of 25 cents per share on net income of $131.9 million, according to estimates compiled by FactSet.
Zoll said gross income from LifeVest, which detects life-threatening heart rhythms and delivers tense shocks to correct them, rose 45 percent to $32.3 million in the three months ended Jan. 1. In North America, sales of products other than LifeVest rose 18 percent to $68.3 million, while its cosmopolitan sales edged up to $33.2 million from $32.8 million. Sales of temperature-guidance devices rose to $7.5 million from $5.
Source: CBS News